Prosecution Insights
Last updated: May 29, 2026

Examiner: KAUP, SAHANA S

Tech Center 1600 • Art Units: 1612 1639 1675 1684

This examiner grants 44% of resolved cases

Performance Statistics

44.1%
Allow Rate
-15.9% vs TC avg
516
Total Applications
+29.5%
Interview Lift
1349
Avg Prosecution Days
Based on 488 resolved cases, 2023–2026

Rejection Statute Breakdown

2.4%
§101 Eligibility
7.4%
§102 Novelty
62.2%
§103 Obviousness
1.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17700088 METHODS AND COMPOSITIONS FOR NUCLEIC ACID SEQUENCING Non-Final OA ILLUMINA, INC.
17889811 Cellular Coding Constructs Providing Identification of Cellular Entities Final Rejection The General Hospital Corporation
17799323 METHODS FOR CELL-FREE PROTEIN EXPRESSION Final Rejection Nuclera Ltd
17839272 Methods and Reagents for Molecular Barcoding Non-Final OA CS GENETICS LIMITED
17441692 EXOSOMES CONTAINING RNA WITH SPECIFIC MUTATION Non-Final OA APPLIED STEMCELL, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month